Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan
| Autor: | Alan I. Green, Jibran Y. Khokhar, David T. Chau, Ree Dawson |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male Alcohol Drinking medicine.drug_class Atypical antipsychotic Alcohol use disorder Pharmacology Toxicology Article Eating Norepinephrine reuptake inhibitor Idazoxan Desipramine medicine Haloperidol Animals Humans Pharmacology (medical) Clozapine Adrenergic Uptake Inhibitors Dose-Response Relationship Drug Mesocricetus Receptors Dopamine D2 business.industry Drug Synergism Adrenergic alpha-2 Receptor Antagonists medicine.disease Typical antipsychotic Psychiatry and Mental health Anesthesia Female business medicine.drug |
| Zdroj: | Drug and Alcohol Dependence. 152:277-281 |
| ISSN: | 0376-8716 |
| Popis: | Background Alcohol use disorder commonly occurs in patients with schizophrenia. Most antipsychotic drugs do not lessen alcohol use; although the atypical antipsychotic clozapine has been shown to reduce alcohol use in patients with schizophrenia, its toxicity severely limits its use in patients. With an eye toward creation of a safer clozapine-like drug, we have investigated the pharmacological basis of the clozapine's effects on alcohol drinking in the Syrian golden hamster. In this animal, as in patients with schizophrenia, clozapine reduces alcohol drinking while the typical antipsychotic haloperidol does not. We have suggested that clozapine decreases alcohol drinking due to its weak dopamine D2 receptor blockade, its potent norepinephrine α-2 receptor antagonism, as well as its ability to elevate plasma norepinephrine. Methods We recreated a clozapine-like drug to reduce alcohol drinking in the Syrian golden hamster by combining low dose haloperidol with a norepinephrine α-2 receptor antagonist, idazoxan, and a norepinephrine reuptake inhibitor, desipramine. Hamsters were given free access to water and alcohol (15% v/v) and were treated daily with each drug or with the three-drug combination for 23 days. Results The drug combination reduced alcohol drinking and preference significantly as compared to vehicle or to haloperidol, idazoxan or desipramine, while not altering food-intake or body-weight. Conclusion These findings suggest that that haloperidol, which does not reduce alcohol drinking in patients with schizophrenia or the hamster, if combined with idazoxan and desipramine (producing a drug combination that mimics aspects of clozapine's pharmacology) is able to reduce alcohol drinking in the hamster. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect